000 | 04236nlm1a2200505 4500 | ||
---|---|---|---|
001 | 662484 | ||
005 | 20231030041823.0 | ||
035 | _a(RuTPU)RU\TPU\network\33639 | ||
035 | _aRU\TPU\network\31630 | ||
090 | _a662484 | ||
100 | _a20200821a2020 k y0engy50 ba | ||
101 | 0 | _aeng | |
135 | _adrcn ---uucaa | ||
181 | 0 | _ai | |
182 | 0 | _ab | |
200 | 1 |
_aAntihypertensive activity of a new c-Jun N-terminal kinase inhibitor in spontaneously hypertensive rats _fM. B. Plotnikov, O. I. Aliev, A. Yu. Shamanaev [et al.] |
|
203 |
_aText _celectronic |
||
300 | _aTitle screen | ||
330 | _ac-Jun N-terminal kinases (JNKs) are involved in the myocardial and aortic remodeling, increased arterial tone, and arterial blood pressure elevation associated with hypertension. The aim of the present study was to investigate the antihypertensive effect of a new JNK inhibitor, 1H-indeno[1,2-b]quinoxalin-11-one oxime sodium salt (IQ-1S), on spontaneously hypertensive rats (SHRs). Experiments were performed using normotensive Wistar-Kyoto (WKY) rats and SHRs. Experimental groups of SHRs received IQ-1S intragastrically for 6 weeks in daily doses of 5 and 50?mg/kg; experimental groups of WKY rats received 50?mg/kg IQ-1S according to the same regimen. The IQ-1S administration regimen induced decreases in systolic blood pressure, mean arterial blood pressure, total peripheral resistance, blood viscosity, hematocrit, myocardial cell cross-sectional area, and aortic wall thickness in SHRs vs untreated SHRs. There were no significant differences in systolic blood pressure values between the control and experimental groups of WKY rats during the treatment period. A concentration-dependent decrease in the tone of carotid arterial rings isolated from SHRs was observed after JNK inhibitor application in vitro. Application of the JNK inhibitor diminished endothelin-1 secretion by human umbilical vein endothelial cells in vitro. The main mechanisms of the antihypertensive effect of IQ-1S included the attenuation of blood viscosity due to decreased hematocrit, a vasodilatory effect on arterial smooth muscle cells, and a decrease in endothelin-1 production by endothelial cells. | ||
461 | _tHypertension Research | ||
463 |
_tVol. 43 _v[P. 1068–1078] _d2020 |
||
610 | 1 | _aэлектронный ресурс | |
610 | 1 | _aтруды учёных ТПУ | |
610 | 1 | _aJNK inhibitor | |
610 | 1 | _a1H-indeno[1,2-b]quinoxalin-11-one oxime sodium salt | |
610 | 1 | _aantihypertensive activity | |
610 | 1 | _ainhibition of myocardial and aorta remodeling | |
610 | 1 | _aendothelin-1 production by endothelial cells | |
610 | 1 | _aингибиторы | |
610 | 1 | _aнатриевая соль | |
701 | 1 |
_aPlotnikov _bM. B. _gMark Borisovich |
|
701 | 1 |
_aAliev _bO. I. _gOleg Ibragimovich |
|
701 | 1 |
_aShamanaev _bA. Yu. _gAleksandr Yurjevich |
|
701 | 1 |
_aSidekhmenova _bA. V. _gAnastasiya Vitaljevna |
|
701 | 1 |
_aAnishchenko _bA. M. _gAnna Mikhaylovna |
|
701 | 1 |
_aFomina _bT. I. _gTatjyana Ivanovna |
|
701 | 1 |
_aRydchenko _bV. S. _gVictoria Sergeevna |
|
701 | 1 |
_aKhlebnikov _bA. I. _cChemist _cProfessor of Tomsk Polytechnic University _f1963- _gAndrey Ivanovich _2stltpush _3(RuTPU)RU\TPU\pers\33927 |
|
701 | 1 |
_aAnfinogenova _bYa. J. _cLinguist _cLecturer of Tomsk Polytechnic University, Doctor of medical sciences _f1970- _gYana Jonovna _2stltpush _3(RuTPU)RU\TPU\pers\33592 |
|
701 | 1 |
_aShchepyotkin _bI. A. _cdoctor-biophysicist _cleading researcher of Tomsk Polytechnic University, candidate of medical science _f1962- _gIgor Aleksandrovich _2stltpush _3(RuTPU)RU\TPU\pers\37358 |
|
701 | 1 |
_aAtochin _bD. N. _cneuroscientist _cThe Head of the Laboratory of Tomsk Polytechnic University _f1960- _gDmitry Nikolaevich _2stltpush _3(RuTPU)RU\TPU\pers\37514 |
|
712 | 0 | 2 |
_aНациональный исследовательский Томский политехнический университет _bИнженерная школа новых производственных технологий _bНаучно-образовательный центр Н. М. Кижнера _h7872 _2stltpush _3(RuTPU)RU\TPU\col\23556 |
801 | 2 |
_aRU _b63413507 _c20201103 _gRCR |
|
856 | 4 | _uhttps://doi.org/10.1038/s41440-020-0446-9 | |
942 | _cCF |